Emerging Markets Equity Monthly Product Commentary: August 2012

Related Videos

1. 
   Will Life Sciences Firms Fall Off the Fiscal Cliff?

   Even if the NIH is drastically cut, we don't see a doomsday scenario for these companies, and some of the industry's stronger players are now trading at attractive valuations.
2. 
   Taking Action

    
3. 
   Will U.S. Hit a BRIC Wall?

   Slowing in some emerging markets likely affects other emerging markets more than it harms the U.S. economy, says Morningstar's Bob Johnson.
4. 
   Trying to Hold On

   Industry headwinds could slow down some companies, but further central bank moves and improving housing data offer the economy much-needed support.